Clive Mason
Programme Director AMR, LifeArc
A highly motivated and experienced drug discovery and biotechnology leader. Passionate about finding solutions and addressing the challenge of antimicrobial resistance (AMR). Innovating in novel antimicrobial R&D as a scientific founder of Discuva Ltd, prior to acquisition by Summit Therapeutics. Now Programme Lead for LifeArc within the newly established, UK-based, PACE initiative.